Stay updated on Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    An NIH announcement about terminology during the agency’s transition appears on the page, and the site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.5%
    Check dated 2026-10-20T21:53:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1, reflecting a website software update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-10-06T22:05:04.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study record's revision label was updated from v3.6.6 to v3.7.0. This reflects a new version of the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:35:44.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study history, and the previous entry v3.6.5 was removed. This is an update to the record's revision metadata on ClinicalTrials.gov rather than substantive content.
    Difference
    0.1%
    Check dated 2026-09-01T18:03:38.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the study history as the latest revision. The previous v3.6.4 entry was removed from the current change set.
    Difference
    0.1%
    Check dated 2026-08-11T22:18:59.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The revision label on the page history updated from v3.6.3 to v3.6.4, signaling a software update to the page rendering system.
    Difference
    0.1%
    Check dated 2026-07-21T13:42:10.000Z thumbnail image

Stay in the know with updates to Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.